Mast To Develop Vepoloxamer (MST-188) In Chronic Heart Failure

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/24/2026

1. META
2. OKTA
3. ORCL
4. SPY
5. P
6. MCD
7. MGM
8. NVDA
9. GDDY
10. ACAD

Go back to Mast To Develop Vepoloxamer (MST-188) In Chronic Heart Failure
MAST THERAPEUTICS, Inc. (NASDAQ: MSTX) Delayed: 20.54 -0.1 (0.48%)
Previous Close $20.64    52 Week High $0.71 
Open $20.30    52 Week Low $0.07 
Day High $21.32    P/E N/A 
Day Low $19.61    EPS $-0.35 
Volume 7,008,616       

MAST THERAPEUTICS, Inc. (NASDAQ: MSTX) Delayed: 20.54 -0.1 (0.48%)
Previous Close $20.64    52 Week High $0.71 
Open $20.30    52 Week Low $0.07 
Day High $21.32    P/E N/A 
Day Low $19.61    EPS $-0.35 
Volume 7,008,616